Lei Sun
CEO
NewLab Biotechnology (Chengdu) Co., Ltd
Shanghai, China
8 profile visitsAttendee
My organisation
NewLab Biotechnology (Chengdu) Co., Ltd
NewLab Biotechnology (Chengdu) Co., Ltd
Corporate/Enterprise
Chengdu, China
NewLab Biotechnology has accumulated experience in nearly 400 preclinical translational research projects of innovative pharmaceuticals and medical devices, having helped partners secure over 30 clinical trial approvals in China, 2 in the US, and more than 5 marketing authorizations, while leading or participating in research projects with a total funding scale of tens of millions. We are also an innovation accelerator specializing in the cardiovascular field, integrating "medical-engineering-R&D + research-production-investment" models, with a proven track record of spearheading the regulatory approval and commercialization of structural heart products including TAVR.
About me
Mr Lei Sun is the Founder and CEO of NewLab Biotechnology (Chengdu) Co., Ltd., a young entrepreneur and an innovation driver in the biopharmaceutical field. He founded NewLab Bio in 2022, anchoring the core positioning of "the strongest innovation engine for pharmaceutical and medical device research, and the most trusted R&D external brain for customers", and leading the company to build a high-standard preclinical R&D service platform for pharmaceuticals and medical devices from scratch.